Targeting host-virus interactions: in silico analysis of the binding of human milk oligosaccharides to viral proteins involved in respiratory infections
Open Access
- 19 February 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-13
Abstract
Respiratory viral infections, a major public health concern, necessitate continuous development of novel antiviral strategies, particularly in the face of emerging and re-emerging pathogens. In this study, we explored the potential of human milk oligosaccharides (HMOs) as broad-spectrum antiviral agents against key respiratory viruses. By examining the structural mimicry of host cell receptors and their known biological functions, including antiviral activities, we assessed the ability of HMOs to bind and potentially inhibit viral proteins crucial for host cell entry. Our in silico analysis focused on viral proteins integral to host-virus interactions, namely the hemagglutinin protein of influenza, fusion proteins of respiratory syncytial and human metapneumovirus, and the spike protein of SARS-CoV-2. Using molecular docking and simulation studies, we demonstrated that HMOs exhibit varying binding affinities to these viral proteins, suggesting their potential as viral entry inhibitors. This study identified several HMOs with promising binding profiles, highlighting their potential in antiviral drug development. This research provides a foundation for utilizing HMOs as a natural source for designing new therapeutics, offering a novel approach in the fight against respiratory viral infections.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Biosynthesis of human milk oligosaccharides via metabolic engineering approaches: current advances and challengesCurrent Opinion in Biotechnology, 2022
- Recent understanding of human milk oligosaccharides in establishing infant gut microbiome and roles in immune systemFood Research International, 2022
- Human milk oligosaccharides and infant gut microbiota: Molecular structures, utilization strategies and immune functionCarbohydrate Polymers, 2022
- COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conferenceAntiviral Research, 2021
- Biotechnologically produced fucosylated oligosaccharides inhibit the binding of human noroviruses to their natural receptorsJournal of Biotechnology, 2020
- Production of HMOs using microbial hosts — from cell engineering to large scale productionCurrent Opinion in Biotechnology, 2019
- Human norovirus inhibition by a human milk oligosaccharideVirology, 2017
- GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX, 2015
- Sialic acid and sialyl‐lactose glyco‐conjugates: design, synthesis and binding assays to lectins and swine influenza H1N1 virusJournal of Peptide Science, 2011
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009